Connect with us
Congo’s Bundibugyo Ebola outbreak has killed 3,007 people, and the only licensed shot now going into arms is still a Zaire vaccine WHO will not endorse...
Medicare's GLP-1 Bridge sells Wegovy and Zepbound for $50, then routes sleep apnea and diabetes patients back to Part D copays of hundreds of dollars.
The 2026 heart attack definition recodes SCAD and spasm as primary attacks and requires sex-specific troponin cutoffs.
Hospital lobbyists want Medicaid cuts rolled back, yet the rural fund caps hospital care pay at 15 percent before 2027 work rules hit.
Rasonque nearly doubled last-line pancreatic survival in RASolute 302, then arrived at $39,800 for 30 days, with a copay path that often skips Medicare.
Elecsys pTau217 is cleared for adults 55 and older, but a positive or intermediate Alzheimer's blood test still needs backup.
AstraZeneca’s Wainua miss lets stabilizer drugs claim first-line ATTR-CM care as Alnylam defends Amvuttra’s trial design.
